These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic engineering of attenuated malaria parasites for vaccination. Khan SM; Janse CJ; Kappe SH; Mikolajczak SA Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204 [TBL] [Abstract][Full Text] [Related]
3. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine. Kreutzfeld O; Müller K; Matuschewski K Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583 [TBL] [Abstract][Full Text] [Related]
4. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848 [TBL] [Abstract][Full Text] [Related]
5. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine. Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072 [TBL] [Abstract][Full Text] [Related]
6. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Mueller AK; Labaied M; Kappe SH; Matuschewski K Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261 [TBL] [Abstract][Full Text] [Related]
7. New pieces for the malaria liver stage puzzle: where will they fit? Mota MM; Rodriguez A Cell Host Microbe; 2008 Feb; 3(2):63-5. PubMed ID: 18312840 [TBL] [Abstract][Full Text] [Related]
8. Vaccination using radiation- or genetically attenuated live sporozoites. Vaughan AM; Kappe SH Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804 [TBL] [Abstract][Full Text] [Related]
9. Protective immunity against malaria liver stage after vaccination with live parasites. Rénia L Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710 [TBL] [Abstract][Full Text] [Related]
10. Malaria--there could be a third way. Miles MA Nature; 2003 Jan; 421(6918):13. PubMed ID: 12511928 [No Abstract] [Full Text] [Related]
11. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Aly AS; Downie MJ; Mamoun CB; Kappe SH Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947 [TBL] [Abstract][Full Text] [Related]
12. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. Putrianti ED; Silvie O; Kordes M; Borrmann S; Matuschewski K J Infect Dis; 2009 Mar; 199(6):899-903. PubMed ID: 19434915 [TBL] [Abstract][Full Text] [Related]
13. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development. Inoue M; Tang J; Miyakoda M; Kaneko O; Yui K; Culleton R Int J Parasitol; 2012 Aug; 42(9):859-70. PubMed ID: 22846785 [TBL] [Abstract][Full Text] [Related]
14. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550 [TBL] [Abstract][Full Text] [Related]
15. Time for Genome Editing: Next-Generation Attenuated Malaria Parasites. Singer M; Frischknecht F Trends Parasitol; 2017 Mar; 33(3):202-213. PubMed ID: 27793562 [TBL] [Abstract][Full Text] [Related]